011000 — Gene One Life Science Balance Sheet

0.000.00%

Last trade - 00:00

Consumer CyclicalsHighly SpeculativeMicro CapSucker Stock

Annual balance sheet for Gene One Life Science, fiscal year end - December 31st, KRW millions except per share, conversion factor applied.

	R2021 December 31st	2022 December 31st	2023 December 31st	2024 December 31st	2025 December 31st
Period Length:	—	—	—	—	—
Source:	Annual Audited Accounts	Annual Audited Accounts	Annual Audited Accounts	Annual Audited Accounts	Annual Audited Accounts
Standards:	IFRS	IFRS	IFRS	IFRS	IFRS
Status:	Final	Final	Final	Final	Final
Cash
Cash and Equivalents
Short Term Investments
Cash and Short Term Investments	108,209	45,851	10,068	1,180	1,550
Net Total Accounts Receivable
Net Total Receivables	9,413	10,579	7,572	8,310	2,663
Total Inventory
Prepaid Expenses
Total Other Current Assets
Total Current Assets	134,633	73,063	34,573	28,635	19,437
Net Property, Plant And Equipment	110,382	144,369	111,399	117,730	95,400
Net Intangible Assets
Long Term Investments
Other Long Term Assets
Total Assets	250,857	222,867	151,008	151,334	119,207
Accounts Payable
Accrued Expenses
Notes Payable / Short Term Debt
Current Portion of Long Term Debt / Capital Leases
Total Other Current Liabilities
Total Current Liabilities	34,759	33,836	22,867	42,506	53,806
Long Term Debt
Capital Lease Obligations
Total Long Term Debt
Total Debt
Deferred Income Tax
Total Other Liabilities
Total Funded Status
Total Liabilities	44,350	41,395	39,518	65,729	78,309
Common Stock
Additional Paid In Capital
Retained Earnings (Accumulated Deficit)
Treasury Stock
ESOP Debt Guarantee
Unrealized Gain / Loss
Other Equity
Total Equity	206,507	181,471	111,489	85,605	40,898
Total Liabilities & Shareholders' Equity	250,857	222,867	151,008	151,334	119,207
Total Common Shares Outstanding